The Dossier

Share this post

Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron

dossier.substack.com

Same junk, different name: Novavax will…

Jordan Schachtel
Jun 8, 2022
182
45
Share this post

Same junk, different name: Novavax will pursue indefinite boosting, and there's no trial data on Omicron

dossier.substack.com

Prior to COVID Mania, Novavax and its competitors had never brought a product to market

Read →
  • New First
  • Chronological
© 2023 Jordan Schachtel
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing